AUTHOR NAME

Bob Edwards

53 POSTS
0 COMMENTS

Building Your Psychedelic Portfolio: A Case Study On Valuating Emergent Biotech

In recent years a cultural shift has occurred bringing psychedelics to the forefront of pharmaceutical sciences. Pair that with legislation being passed to decriminalize psilocybin in Denver, Oakland, and...

How Does MDMA Help Patients With PTSD, And Which Pharmaceutical Companies Are Leading The Way For The Coming Revolution In Therapy?

“The biology of PTSD is one of the body changing to accommodate a new reality” states Dr. Rachel Yehuda in a February 2021 interview for ‘The Psychedelic Therapy’ podcast....

Bill to legalize possession of psychedelics in California heads to the Senate floor after committee action.

A landmark bill that seeks to legalize the possession of psychedelic substances in California is now due to be reviewed by the State Senate after clearing a major procedural...

Scientific insight into the future of psychedelics

May 2021 marks the second anniversary of establishing the world’s first dedicated center for research into the action and clinical use of psychedelic compounds at Imperial College London. It...

These Psychedelic Patents Could Be The Turning Point For A Medical Breakthrough

Recent efforts to legalize psychedelics for medical and recreational purposes have intensified after the legalization of drugs under Schedule I controlled substances designated by the Controlled Substances Act of...

Psychedelic Testing to be Conducted by Mycotopia Therapies and Natural MedTech Joint Venture

Mycotopia Therapies, a company focused on psychedelic therapy, has recently announced the formation of ‘PsyBioMed-Australia,’ a joint venture between itself and Natural MedTech. Through a formal letter of intent,...

Algernon Pharmaceuticals Announces its Addition to the Market’s First Psychedelic Stock Index ETF

Vancouver-based clinical-stage pharmaceutical company Algernon Pharmaceuticals was recently added to the Horizons Psychedelic Stock Index ETF (PSYK) in the index’s first quarterly rebalance of holdings for 2021. PSYK is...

Peter Thiel-backed Magic Mushroom firm Atai is now worth a whopping $2 billion

German biotech company Atai Life Sciences is all set to become one of the first licensed producers of psilocybin and other psychoactive medicinal substances in the U.S. Atai aims...

Psychedelic for meth users: Sydney trial aims to conquer addiction

A historical clinical trial being conducted in Sydney can essentially pave the way for psychedelic medicine to seep into the mainstream. The trial aims to study the effect of...

Numinus Bioscience announces 7,500 square foot expansion to its Nanaimo BC Lab

By late 2021, Numinus Bioscience plans to add 7,500 square feet to their state-of-the-art lab in Nanaimo BC in order to accelerate intellectual property development and to increase psychedelic supply capacity....
COMPASS Pathways Plc - American  CMPS 
$31.62  0.80%  
   
$0.0000  0.00%  
MIND MEDICINE (MINDMED) INC.  MMED.NE 
$3.06  0.00%  
TrypTherapeutic  TRYP.CN 
$0.3650  -2.67%  
AionTherapeutic  AION.CN 
$0.0450  0.00%  
BetterPlantSci  PLNT.CN 
$0.0450  0.00%  
CaptivaVerde  PWR.CN 
$0.1200  0.00%  
   
$0.0000  0.00%  
CodebaseVent  CODE.CN 
$0.1400  0.00%  
CoreOneLabs  COOL.CN 
$2.40  -4.38%  
CYBIN INC.  CYBN.NE 
$2.72  -1.09%  
EGFThera  TMED.CN 
$0.0700  -6.67%  
EHAVE INC  EHVVF 
$0.0250  2.04%  
EmpowerClinInc  CBDT.CN 
$0.4300  -3.37%  
Entheon Biomed  ENBI.CN 
$0.3000  3.45%  
GLOBAL TRAC SOLUTIONS INC  PSYC 
$0.0098  1.03%  
GraphBlockInc  GBLC.CN 
$0.0500  0.00%  
HAVNLifeSci  HAVN.CN 
$0.3100  8.77%  
HOLLISTER BIOSCIENCES INC  HSTRF 
$0.1791  -2.13%  
LobeSciences  LOBE.CN 
$0.0450  0.00%  
MindCureHealth  MCUR.CN 
$0.3450  0.00%  
MindsetPharma  MSET.CN 
$0.8400  3.70%  
MINERCO INC  MINE 
$0.0001  0.00%  
MYDECINE INNOVATIONS GROUP INC  MYCOF 
$0.2758  -1.50%  
NEONMIND BIOSCIENCES INC  NMDBF 
$0.0762  -12.22%  
NEW WAVE HLDGS CORP  TRMNF 
$0.3878  15.66%  
NovaMentisLife  NOVA.CN 
$0.0900  0.00%  
Novamind Inc.  NM.CN 
$0.6000  -3.23%  
NUMINUS WELLNESS INC  NUMI.V 
$0.8400  0.00%  
NutritionalHi  EAT.CN 
$0.1250  -7.41%  
   
$0.0000  0.00%  
PsyenceGroup  PSYG.CN 
$0.1600  0.00%  
RED LIGHT HOLLAND CORP  TRUFF 
$0.1690  -6.11%  
REVIVE THERAPEUTICS LTD  RVVTF 
$0.3631  3.15%  
ROADMAN INVESTMENTS CORP  LITT.V 
$0.0250  0.00%  
Seelos Therapeutics, Inc.  SEEL 
$2.16  13.68%  
SILO PHARMA INC  SILO 
$0.1902  14.58%  
THOUGHTFUL BRANDS INC  PEMTF 
$0.0724  20.58%  
WUHAN GENERAL GROUP CHINA INC  WUHN 
$0.5603  -9.63%  
PharmaTher  PHRM.CN 
$0.8100  2.53%  
OptimiHealth  OPTI.CN 
$0.6000  -1.64%